Projects

• NEWTBVAC
• TBVAC
• INYVAX
• TRANSVAC
• ADITEC
• TBTEA
• MYCOWALC
• ESI TBVI
• TBVI Advocacy & Fundraising

1. TBVI »
2. Projects

By linking the greatest research institutes in Europe and around the world, TBVI is increasing the chances of finding the best solutions for tuberculosis. Research done by our network has already resulted in new vaccine discoveries, discoveries in vaccine enhancing adjuvants, and new biomarkers for monitoring clinical trials.

After successfully coordinating the TBVAC project (2004-2009), TBVI now coordinates its successor NEWTBVAC (2010-2014). Both projects are Framework Programs funded by the European Union to identify new TB vaccine candidates. Around 35 universities, research institutes and industries are involved: TBVI coordinates, facilitates, supports and brings expertise to this network.

Furthermore, TBVI is partner in INYVAX, a project aiming to optimize the development of vaccines against poverty-related diseases.

Next to research projects, we run the Establishment, Strategy and Initial Activities of the TuBerculosis Vaccine Initiative (ESI TBVI). As well as the TBVI Advocacy and Fundraising project supported by a grant from the Bill & Melinda Gates Foundation.